Development company Merus purchased Nashville's RiverGate Mall for $33 million. The developer plans a $450 million mixed-use project with housing, retail and restaurants. Construction is expected to ...
Hosted on MSN
Merus N.V.'s SWOT analysis: biotech firm's stock poised for growth amid clinical trials
Merus N.V. (NASDAQ:MRUS), a biotechnology company specializing in innovative antibody-based therapies with a market capitalization of $2.75 billion, has garnered significant attention from analysts ...
Phase 3 registrational trials evaluating petosemtamab in combination with pembrolizumab in 1L and petosemtamab monotherapy in 2/3L r/m HNSCC enrolling Petosemtamab in 2L+ r/m HNSCC interim clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results